Group 1 - Yidu Technology repurchased 190,000 shares at an average price of HKD 5.13 per share, totaling approximately HKD 974,400, with a cumulative repurchase of 7.23 million shares this year, representing 0.68% of the total share capital [1] - The company's stock price increased by 4.02% to HKD 5.17 per share following the repurchase announcement [1] - The repurchase activity reflects management's confidence in the company's future prospects, especially as the stock price has declined approximately 80% from its peak in 2021 [1] Group 2 - Yidu Technology, established in 2014, went public on the Hong Kong Stock Exchange in January 2021, with the stock code 2158.HK [2] - The company operates in the medical artificial intelligence sector, focusing on big data platform solutions, life sciences solutions, and health management platforms, with its proprietary "medical brain" YiduCore processing over 300 million patient medical data [2] - In the fiscal year 2023, Yidu Technology achieved revenue of RMB 1.23 billion, maintaining a research and development investment ratio of over 40% [2] - The company recently received the first real-world data research medical device registration certificate from the National Medical Products Administration, indicating regulatory recognition of its technological capabilities [2] - Yidu Technology is transitioning from a technology service provider to a medical value creator amid the acceleration of digital healthcare infrastructure [2]
医渡科技回购19.00万股股票，共耗资约97.44万港元，本年累计回购723.13万股